Downregulated CCND3 Is a Key Event Driving Lung Adenocarcinoma Metastasis during Acquired Cisplatin Resistance
International Journal of Biological Sciences · 01.01.2025 · 21 (2) · 708-724
DOI: 10.7150/ijbs.100921 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biological Sciences, erschienen am 01.01.2025. Verfasst von Yun Su und 18 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, Guangzhou Medical University, Guangzhou 511436, …. Hauptthemen laut MEDLINE: Cisplatin, Lung Neoplasms, Adenocarcinoma of Lung, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, Guangzhou Medical University, Guangzhou 511436, China.
- Department of Cardiothoracic Vascular Surgery, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.
- Department of Pulmonary and Critical Care Medicine Peking University Shenzhen Hospital, Shenzhen 518036, China.
- School of Pharmacy, Guangdong Medical University, Dongguan 523808, China.
- Department of Otolaryngology, Shenzhen Longgang Otolaryngology Hospital, Shenzhen 518172, China.
- The People's Hospital of Gaozhou, Gaozhou 525200, China.
Zitieren
APA
Su, Y., Ma, Y., Wang, Y., Xu, P., Guo, M., Cao, H., Xin, J., Wu, X., Liu, X., Chen, S., Tao, X., Yang, H., Cheng, C., Huang, R., Pan, R., Pan, Y., Zhou, B., Fang, W., & Liu, Z. (2025). Downregulated CCND3 Is a Key Event Driving Lung Adenocarcinoma Metastasis during Acquired Cisplatin Resistance. International Journal of Biological Sciences, 21(2), 708-724. https://doi.org/10.7150/ijbs.100921
Vancouver
Su Y, Ma Y, Wang Y, Xu P, Guo M, Cao H, et al. Downregulated CCND3 Is a Key Event Driving Lung Adenocarcinoma Metastasis during Acquired Cisplatin Resistance. International Journal of Biological Sciences. 2025;21(2):708-724. doi:10.7150/ijbs.100921
BibTeX
@article{Su2025,
author = {Su, Yun and Ma, Yuting and Wang, Yubing and Xu, Ping and Guo, Miaoling and Cao, Haolin and Xin, Jianyang and Wu, Xi and Liu, Xiaoyan and Chen, Shan and Tao, Xingyu and Yang, Huiling and Cheng, Chao and Huang, Rongquan and Pan, Rongshuai and Pan, Yuexin and Zhou, Beixian and Fang, Weiyi and Liu, Zhen},
title = {Downregulated CCND3 Is a Key Event Driving Lung Adenocarcinoma Metastasis during Acquired Cisplatin Resistance},
journal = {International Journal of Biological Sciences},
year = {2025},
volume = {21},
number = {2},
pages = {708--724},
doi = {10.7150/ijbs.100921}
}
EUVIMED